pulmolytic Pages on BioPortfolio:

BioPortfolio - AEROVANCE, INC - Profile
PULMOLYTIC™, a serine protease inhibitor in Phase 2a for COPD. Aerovance was spun off from Bayer Healthcare's biotechnology unit in August 2004 and has a ...
http://www.bioportfolio.com/biocorporate/17964-AEROVANCE,+IN...

Results from other life science and pharmaceutical sites:

Corporate Profile : Start-Up Firm Touts Mid-Stage Pipeline Genetic ...
15 Sep 2007 ... Aerolytic and Pulmolytic are based on a truncated serine protease inhibitor. ... Pulmolytic reportedly shows potential to normalize fluid ...
http://www.genengnews.com/biobusiness/cpitem.aspx?aid=2202&c...

BioWorld Today
28 Mar 2007 ... Aerovance also completed a Phase IIa chronic obstructive pulmonary disease study of Pulmolytic, which shares the same mechanism of action as ...
http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher...

Open pulmolysis in the treatment of pulmonary tube...[Acta Tuberc ...
PubMed is a service of the US National Library of Medicine that includes over 18 million citations from MEDLINE and other life science journals for ...
http://www.ncbi.nlm.nih.gov/pubmed/13007522...

The Surgical Treatment of Pulmonary Tuberculosis in Childhood and ...
[PubMed]; RUDSTROM P, HEDVALL E. Open pulmolysis in the treatment of pulmonary tuberculosis. Acta Tuberc Scand. 1952;27(1-2):38–46. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=10...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.